Abstract
Kaposi sarcoma (KS) is a vascular neoplasm mainly affecting the skin of the limbs that has previously been associated with rheumatoid arthritis (RA). When compared with the RA patients treated with corticosteroids and immunosuppressive drugs, the reported number of KS in RA patients was very rare. Although the exact mechanisms of developing KS in RA patients are unclear, some drugs which include corticosteroid have been suggested as an etiological factor in previous case reports of RA and KS. We report, here in, another case of KS associated with the initiation of leflunomide in a patient with RA.
This is a preview of subscription content, log in via an institution to check access.
References
Martin RW 3rd, Hood AF, Farmer ER (1993) Kaposi sarcoma. Medicine (Baltimore) 72:245–261
Casoli P, Tumiati B (1992) Rheumatoid arthritis, corticosteroid therapy and Kaposi’s sarcoma: a coincidence? A case and review of literature. Clin Rheumatol 11:432–435
Larbre JP, Nicolas JF, Collet P, Larbre B, Llorca G (1991) Kaposi’s sarcoma in a patient with rheumatoid arthritis possible responsibility of captopril in the development of lesions. J Rheumatol 18:476–477
Vincent T, Moss K, Colaco B, Venables PJ (2000) Kaposi’s sarcoma in two patients following low-dose corticosteroid treatment for rheumatological disease. Rheumatology (Oxford) 39:1294–1296
Cohen CD, Horster S, Sander CA, Bogner JR (2003) Kaposi’s sarcoma associated with tumour necrosis factor alpha neutralising therapy. Ann Rheum Dis 62:684
Louthrenoo W, Kasitanon N, Mahanuphab P, Bhoopat L, Thongprasert S (2003) Kaposi’s sarcoma in rheumatic diseases. Semin Arthritis Rheum 32:326–333
Schottstaedt MW, Hurd ER, Stone MJ (1987) Kaposi’s sarcoma in rheumatoid arthritis. Am J Med 82:1021–1026
Weiner SR, Noritake DT, Paulus HE (1988) Kaposi’s sarcoma in a patient with rheumatoid arthritis and polymyositis treated with corticosteroids. West J Med 148:702–703
Burnet SP, McNeil JD (2002) Kaposi’s sarcoma in an elderly patient with rheumatoid arthritis after intra-articular corticosteroids. Rheumatology (Oxford) 41:107–108
Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 266:1865–1869
Rady PL, Hodak E, Yen A, Memar O, Trattner A, Feinmesser M, David M, Hudnall SD, Tyring SK (1998) Detection of human herpesvirus-8 DNA in Kaposi’s sarcomas from iatrogenically immunosuppressed patients. J Am Acad Dermatol 38:429–437
Ahmadpoor P (2009) Human herpesvirus-8 and Kaposi sarcoma after kidney transplantation: mechanisms of tumor genesis. Iran J Kidney Dis 3:121–126
Antman K, Chang Y (2000) Kaposi’s sarcoma. N Engl J Med 342:1027–1038
Waldman WJ, Knight DA, Lurain NS, Miller DM, Sedmak DD, Williams JW, Chong AS (1999) Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide. Transplantation 68:814–825
Knight DA, Hejmanowski AQ, Dierksheide JE, Williams JW, Chong AS, Waldman WJ (2001) Inhibition of herpes simplex virus type 1 by the experimental immunosuppressive agent leflunomide. Transplantation 71:170–174
Chong AS, Zeng H, Knight DA, Shen J, Meister GT, Williams JW, Waldman WJ (2006) Concurrent antiviral and immunosuppressive activities of leflunomide in vivo. Am J Transplant 6:69–75
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, S.Y., Jo, Y.M., Chung, W.T. et al. Disseminated cutaneous and visceral Kaposi sarcoma in a woman with rheumatoid arthritis receiving leflunomide. Rheumatol Int 32, 1065–1068 (2012). https://doi.org/10.1007/s00296-009-1354-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-009-1354-0